Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The 'Global Metabolomics Market Report by Product, Indication, Application, and Region 2024-2032' report has been added to ResearchAndMarkets.com's offering.The global metabolomics market has experienced significant growth, with the current valuation at US$ 2.7 Billion in 2023.

都柏林，2024年6月6日（环球通讯社）--“2024-2032年全球代谢组学市场报告（按产品、适应症、应用和地区划分）”已添加到ResearchAndMarkets.com的发行中。全球代谢组学市场经历了显着增长，2023年当前估值为27亿美元。

The market's robust performance is projected to continue, with expectations to reach a value of US$ 6.5 Billion by 2032, propelled by a compound annual growth rate (CAGR) of 10.25% over the forecast period from 2023-2032. Key factors propelling this growth include the increased demand for personalized medicine, a rise in chronic disease prevalence, and advancements in pharmaceutical and biotechnological research.

市场的强劲表现预计将持续下去，预计到2032年将达到65亿美元，这是由2023-2032年预测期内10.25%的复合年增长率（CAGR）推动的。推动这一增长的关键因素包括对个性化医疗的需求增加，慢性病患病率上升以及制药和生物技术研究的进步。

Moreover, the deployment of metabolomics for drug discovery and development is set to foster considerable market expansion.The role of metabolomics in personalized medicine, a pivotal growth driver, enables the tailoring of treatments to individual patient profiles, marking a shift from traditional one-size-fits-all approaches.

此外，代谢组学在药物发现和开发中的应用将促进相当大的市场扩张。代谢组学在个性化医学中的作用是一个关键的增长驱动因素，它可以根据个体患者的情况定制治疗方法，标志着从传统的一刀切的方法转变。

Alongside, the burgeoning incidence rate of chronic diseases globally underscores the need for early detection and preventive healthcare solutions, further catalyzing the metabolomics market's growth trajectory.Contribution of Pharmaceutical and Biotechnology ResearchIn light of pharmaceutical and biotechnology advancements, metabolomics is gaining significant traction within drug discovery and design, with research institutions seeking state-of-the-art methodologies to streamline drug development processes.

此外，全球慢性病发病率的迅速上升突显了对早期发现和预防性医疗保健解决方案的需求，进一步催化了代谢组学市场的增长轨迹。药物和生物技术研究的贡献鉴于药物和生物技术的进步，代谢组学在药物发现和设计方面取得了重大进展，研究机构寻求最先进的方法来简化药物开发过程。

Furthermore, the integration of metabolomics into clinical settings bids well for market enrichment, as it broadens the scope for novel diagnostic and therapeutic avenues.Market Segmentation InsightsA comprehensive .

此外，代谢组学与临床环境的整合很好地丰富了市场，因为它拓宽了新的诊断和治疗途径的范围。市场细分见解全面。

Attachment

附件

Global Metabolomics Market

全球代谢组学市场